Cannabis

France to launch medical cannabis experiment in coming weeks

As a nearly unanimous French Senate gave medical marijuana the green light on May 28, France will start experimenting with the use of medical marijuana for “about two years.” According to patient groups, somewhere between 300,000 and 1 million patients could be eligible to use cannabis to manage symptoms of cancer, certain types of epilepsy, multiple sclerosis, palliative care, and pain that does not respond to usual treatments. #france #cancer #epilepsy #multiplesclerosis #palliativecare #pain http://bit.ly/2WehBoY

Benjamin Caplan, MDFrance to launch medical cannabis experiment in coming weeks
read more

Does cannabis cause psychosis? Evidence is lacking, scientists say

A study in March found that daily use of high-potency cannabis is “strongly linked to the risk of developing psychosis.” But on June 1st, six scientists published a study in The Lancet, a British medical journal, that disputed this claim. The authors of the study note that correlation doesn’t equal causation. In other words, people with schizophrenia may be more likely to use cannabis, but there’s no evidence to suggest that it works the other way around. #psychosis #schizophrenia
The news: http://bit.ly/2WeuM9E
The articles & academic commentary: http://bit.ly/2Wf04wT

Benjamin Caplan, MDDoes cannabis cause psychosis? Evidence is lacking, scientists say
read more

Protection for banks doing business with the cannabis industry

Bills protecting banks from federal punishment for doing business with companies in the cannabis industry are being submitted to Congress. While these bills have specific terms, they will open doors for permanent protection from punishment, which will let the industry flourish http://bit.ly/30Ya0OW

Benjamin Caplan, MDProtection for banks doing business with the cannabis industry
read more